Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Prosidion claims new glucose-dependent insulinotropic receptor agonists

March 2, 2010

FDA grants marketing approval for Shire's VPRIV for type 1 GD

March 1, 2010

Corcept Therapeutics begins phase I CORT-108297 trial

March 1, 2010

Once-weekly exenatide NDA review for type 2 diabetes extended by FDA

Feb. 26, 2010

GSK criticizes Senate Committee on Finance's report on Avandia

Feb. 25, 2010

Shire receives FDA fast track designation for Replagal

Feb. 25, 2010

FDA accepts Arena Pharmaceuticals' lorcaserin NDA for filing

Feb. 25, 2010

Amylin and Takeda to begin phase III trial of pramlintide/metreleptin in obesity

Feb. 23, 2010

Takeda and Affymax begin phase III trial of Hematide in chronic renal failure

Feb. 23, 2010

GSK and FDA present safety update on Avandia for type 2 diabetes

Feb. 23, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...